A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides

Starting soon · Phase 1

Conditions studied: Mycosis Fungoides, Cutaneous T-cell Lymphoma

In brief

This study will evaluate the safety and preliminary efficacy of duvelisib topical gel in participants with early-stage mycosis fungoides.

Key facts

Study ID

NCT07714187

Run by

SecuraBio

People needed

30

Starts

2027-01-01

Expected to finish

2029-01-01

Last updated by the study team

2026-07-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.